Non-Invasive Monitoring Systems (OTCMKTS:NIMU) specializes in the design, development and commercialization of non-invasive hemodynamic monitoring solutions for use in clinical and ambulatory settings. Its flagship technology, the NICaS System, employs whole-body impedance cardiography to provide real-time measurements of stroke volume, cardiac output, systemic vascular resistance and other key cardiovascular parameters. This portable platform delivers continuous, beat-to-beat data without the need for invasive catheters, enhancing patient comfort and reducing procedural risks for healthcare providers.
The company’s product portfolio includes proprietary sensors, software analytics and reporting tools that integrate seamlessly into hospital information systems and telehealth networks. Clinicians use these solutions across a broad spectrum of care environments—ranging from intensive care units and operating rooms to outpatient clinics and remote patient monitoring programs—to guide treatment decisions, optimize fluid management and assess therapeutic response. In addition, NIMU offers training, technical support and data-driven insights to help customers maximize the clinical and economic value of its platforms.
Founded in the late 2000s, NIMU has undergone multiple regulatory clearances in major markets, including CE marking in Europe and FDA 510(k) clearance in the United States. The company maintains research and development operations focused on expanding its non-invasive monitoring capabilities, pursuing enhancements in signal processing, digital connectivity and artificial intelligence. Strategic partnerships with academic institutions and healthcare systems have supported clinical validation studies and facilitated market adoption across cardiology, critical care and sports medicine applications.
Headquartered in North America with regional offices and distribution partners spanning Europe, Asia-Pacific and Latin America, NIMU has cultivated a global footprint geared toward meeting the needs of diverse healthcare environments. The management team comprises seasoned executives with deep expertise in medical device engineering, regulatory affairs and commercial strategy, supported by a board of directors experienced in healthcare innovation. Under this leadership, Non-Invasive Monitoring Systems continues to advance its mission of delivering accurate, user-friendly hemodynamic monitoring solutions that improve patient outcomes and streamline clinical workflows.
AI Generated. May Contain Errors.
Free NIMU Stock Alerts